Michael Retsky has PhD in experimental physics from University of Chicago 1974. He made a career change to cancer research in 1980s while working at Hewlett-Packard in Colorado Springs. He became Prof of Biology at University of Colorado and later visiting Prof in Medical Oncology at University of Texas - San Antonio. He was on Judah Folkman’s staff at Harvard Medical School for 12 years during which time the dormancy research got started. Diagnosed with stage IIIc colon cancer in 1994, he was the first person to use metronomic chemotherapy. He is now on staff at Harvard TH Chan School of Public Health. With Romano Demicheli he edited a book: Perioperative Inflammation as Triggering Origin of Metastasis Development (Springer- Nature 2017). He has 3 patents pending on methods to prevent late relapses. His over 100 papers in Physics and Oncology have been cited over 2500 times.
Catherine Maurice completed her residency training in Neurology at the University of Montreal in 2013. She then started a 2-year fellowship in neuro-oncology at the Pencer Brain Tumor Centre of Princess Margaret Hospital, Toronto, under the supervision of Dr Warren P. Mason. In 2015, University of Toronto Health Network recruited Dr. Catherine Maurice to work as an attending physician and clinical teacher. She developed a new neuro-oncology clinic focusing on the to assessment of neurologic complications resulting from systemic cancers and novel therapies. She also manages another clinic focused on primary brain tumors and is enrolled in the multidisciplinary Gamma-Knife Clinic of the Krembil Neuroscience Centre. Dr. Maurice is actively involved in teaching, trying to incorporate new technologies and virtual reality into medical education.
Brain and Cancer